Adaptive Biotechnologies (ADPT) might move higher on growing optimism about its earnings prospects,

Amova Asset Management Americas Inc. lessened its stake in Adaptive Biotechnologies Corporation (NAS

Approximately 386,000 shares were liquidated for a total transaction value of $8.5 million on July 2

SEATTLE, July 09, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a co

Morgan Stanley analyst Tejas Savant maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Equal

Guggenheim analyst Subbu Nambi maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Buy and ra

U.S. stocks rose, with Nasdaq up 50 points. KB Home (NYSE: KBH) reported strong Q2 results, shares j

Adaptive Biotechnologies Corporation (NASDAQ:ADPT ) on Monday announced plans to separate its Minima

William Blair says Adaptive's Immune Medicine separation could sharpen the MRD story, improve fl

BTIG analyst Mark Massaro reiterates Adaptive Biotechnologies (NASDAQ:ADPT) with a Buy and mainta

Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (NASDAQ:ADPT) today announ

Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement to enhance financial flexib

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) shares are trading higher during Tuesday's sessio

Adaptive Biotechnologies plans to separate its businesses as clonoSEQ profitability and revenue grow

(Editor’s note: The lede, headline, futures and economic data were updated.) U.S. stock futures w

US stock futures up 0.1%, Dave and Buster's (PLAY) down 13.4% pre-market due to lower earnings;

HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open

Stock futures lower, Wiley & Sons and Vince Holding expected to report earnings, Dave & Bust

Adaptive Biotechnologies said on Monday it planned to separate its immune medicine ​business from it

Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial-stage biotechnology company focused

Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement to enhance financial flexib

MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine h

Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement to enhance financial flexib

Chief People Officer Francis Lo disposed of 39,741 Common Stock shares on June 4, 2026, for a total

Adaptive Biotechnologies (ADPT) saw its shares surge in the last session with trading volume being h

Adaptive Biotechnologies NASDAQ: ADPT Chief Executive Officer and Co-Founder Chad Robins said the co

Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that ai

SEATTLE, May 29, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a com

Adaptive Biotechnologies develops immune-driven diagnostics and research tools for the life sciences

SEATTLE, May 21, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a com

Adaptive Biotechnologies Corporation (ADPT) Q1 2026 Earnings Call Transcript

While the top- and bottom-line numbers for Adaptive Biotechnologies (ADPT) give a sense of how the b

  On Thursday, 369 companies hit new 52-week lows.

  During the session on Thursday, 461 stocks hit new 52-week lows.

  Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report qua

  On Wednesday, 807 companies reached new 52-week lows.

  On Friday, 1043 companies hit new 52-week lows.

  On Friday, 431 companies hit new 52-week lows.

    Tuesday's session saw 729 companies set new 52-week lows.

Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Wednesday